08:52 AM EDT, 08/12/2024 (MT Newswires) -- Xenon Pharmaceuticals ( XENE ) said Monday it appointed Matthew Ronsheim as chief operating officer.
Ronsheim, who has more than 25 years of experience, served as president of Innoviva Specialty Therapeutics.